CMSMedicare AdvantagePart D/Prescription Drugs

The 2021 Medicare plans with 5 stars

(By Morgan Haefner for Becker’s Hospital Review)

CMS released its report card for Medicare Advantage and Part D prescription drug plans Oct. 8.

Medicare ranks Medicare Advantage and Part D plans on a quality scale of one to five stars, with five representing excellent performance and one reflecting poor performance. To assign stars, Medicare analyzes how health plans performed on 44 measures for Medicare Advantage and Part D plans; 32 measures for only Medicare Advantage plans; and 14 measures for standalone Part D prescription drug plans.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org

Leave a Reply